Hyperthyroidism as a cause of pulmonary arterial hypertension: A prospective study

Angiology

Volumn 57, Issue 5, 2006, Pages 600-606

  Armigliato, Michela ^a   Paolini, Rossella ^a   Aggio, Silvio ^a   Zamboni, Sergio ^a   Galasso, Maria Paola ^a   Zonzin, Pietro ^a   Cella, Giuseppe ^b  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIHYPERTENSIVE AGENT; IODINE 131; PROPRANOLOL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; PREVALENCE; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THYROIDECTOMY; THYROTOXICOSIS; TOXIC GOITER;

ADULT; AGED; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; HYPERTHYROIDISM; MALE; MIDDLE AGED; PULMONARY ARTERY;

EID: 33749860155     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706293131     Document Type: Article

References (29)

1. Barst RJ, McGoon M, Torbicki A, et al: Diagnosis and differential assessment of pulmonary arterial hypertension. JACC 43:40S-47S, 2004.
2. Farber HW, Loscalzo J: Pulmonary arterial hypertension. N Engl J Med 351:1655-1665, 2004.
3. Shimazaki M, Mitsuhashi T, Hasegawa K: Idiopathic pulmonary hypertension. Nippon Rinsho 38:1783-1786, 1980.
4. Thurnheer R, Jenni R, Russi EW, et al: Hyperthyroidism and pulmonary hypertension. J Internal Med 242:185-188, 1997.
5. 131I treatment. Chest 116:1483-1485, 1999.
6. Arroliga AC, Dweik RA, Rafanan AL: Primary pulmonary hypertension and thyroid disease. Chest 118:1224-1225, 2000.
7. Chu JW, Kao PN, Faul JL, et al: High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 122:1668-1673, 2002.
8. Marvisi M, Brianti M, Marani G, et al: Hyperthyroidism and pulmonary hypertension. Respir Med 96:215-220, 2002.
9. Yazar A, Doven O, Atis S, et al: Systolic pulmonary artery pressure and serum uric acid level in patients with hyperthyroidism. Arch Med Res 34:35-40, 2003.
10. Mercé J, Ferrás S, Oltra C, et al: Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study. Am J Med 118: 126-131, 2005.
11. Biondi B, Palmieri EA, Lombardi G, et al: Effects of thyroid hormone on cardiac function. J Clin Endocrinol Metab 87:968-974, 2002.
12. Ingbar DH: The pulmonary system in thyrotoxicosis. In: The Thyroid, ed. by Braverman LE, Utiger RD. Philadelphia: Lippincott, 2000, pp 605-627.
13. Yanai-Landau H, Amital H, Bar-Dayan Y: Autoimmune aspects of primary pulmonary hypertension. Pathobiology 67:71-75, 1995.
14. Badesc DB, Wynne KM, Bonvallet S, et al: Hypothyroidism and primary pulmonary hypertension: An autoimmune pathogenetic link? Ann Intern Med 119:44-46, 1993.
15. Curnock AL, Dweik RA, Higgins BH: High prevalence of hyperthyroidism in patients with pulmonary hypertension. Am J Med Sci 318:289-292, 1999.
16. Ojamaa K, Klein I, Kenessey A: Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141:2139-2278, 2000.
17. Polikar R, Burger AG, Burger AG, et al: The thyroid and the heart. Circulation 87:1435-1441, 1993.
18. Rich S, Braunwald E, Grossman W: Pulmonary hypertension. In: Heart Disease. A Textbook of Cardiovascular Medicine, ed. by Braunwald E. Philadelphia: Saunders, 1997, pp 780-798.
19. McQuillan BM, Picard MH, Leavitt M, et al: Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 104:2302-2797, 2001.
20. Martin-Duran R, Larman M, Trugeda A, et al: Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol 57:859-863, 1986.
21. Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509, 2001.
22. Guidelines Subcommittee. 1999 World Health Organization: International Society for Hypertension guidelines for the management of hypertension. J Hypertens 17:151-183, 1999.
23. Woeber KA: Thyrotoxicosis and the heart. N Engl J Med 327:94-98, 1992.
24. Moraes D, Loscalzo J: Pulmonary hypertension: Newer concepts in diagnosis and management. Clin Cardiol 20:676-682, 1997.
25. Cella G, Bellotto F, Tona F, et al: Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226-1230, 2001.
26. Letizia C, Centanni M, Cesareo R, et al: Increased plasma levels of endothelin-1 in patients with hyperthyroidism. Metabolism 44:1239-1242, 1995.
27. Cesareo R, Tarabuso A, Di Benedetto M, et al: Plasmatic endothelin-1 levels in hyperthyroid patients before and after antithyroid therapy. Minerva Endocinol 25:1-3, 2000.
28. Lam HC, Lee JK, Lai KH, et al: Plasma endothelin levels are unaltered by thyroid hormone status in humans. J Cardiovasc Pharmacol 36(suppl 1):S382-S385, 2000.
29. Diekman MJ, Harmas MP, Endert E, et al: Endocrine factors related to change in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. Eur J Endocrinol 144:339-346, 2001.